Karen Flynn

Track

Insider profile

Currently holds a position at Catalent Inc

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return -11% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
President - Biologics and Chief Commercial Officer Catalent Inc Jan. 16, 2020 -
Senior Vice President and Chief Commercial Officer West Pharmaceutical Services Inc Jan. 12, 2016 - Dec. 31, 2019
President - Pharmaceutical Packaging Systems West Pharmaceutical Services Inc Aug. 1, 2014 - Jan. 12, 2016
Pharmaceutical Packaging Systems Americas Region West Pharmaceutical Services Inc June 1, 2012 - Aug. 1, 2014
Vice President-sales West Pharmaceutical Services Inc May 1, 2008 - June 1, 2012
Karen Flynn's trades of Stevanato Group SpA's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-26 2026-06-15
S Sale
24,598 -31.3%
169.09
US$1,101,763 		24,598 -31.3% 169.09 US$1,101,763
2022-01-11 2022-01-10
US Catalent Inc (CTLT)
PlS Planned sale
11,836 +10.3%
397.36
US$4,871,715 		11,836 +10.3% 397.36 US$4,871,715
2021-01-11 2021-01-11
US Catalent Inc (CTLT)
PlS Planned sale
97,584 -2.6%
269.44
US$4,143,160 		97,584 -2.6% 269.44 US$4,143,160
2021-01-11 2021-01-11
US Catalent Inc (CTLT)
PlS Planned sale
1,378 -3.7%
112.14
US$154,529 		1,378 -3.7% 112.14 US$154,529
2021-01-05 2021-01-04
US Catalent Inc (CTLT)
PlS Planned sale
99 -0.3%
104.42
US$10,338 		99 -0.3% 104.42 US$10,338